Navigation Links
Latest Research Findings for Autism
Date:8/29/2013

Sturgeon Bay, WI (PRWEB) August 29, 2013

A person with the neurodevelopmental disorder autism commonly displays impaired social and communication skills, along with restricted, repetitive, and stereotyped behavioral patterns, interests, and activities. Sturgeon Bay, Wisconsin Chiropractor and Naturopath, Dr. J G Moellendorf, DC, ND, LCP states that the world-wide increase in autism has reached epidemic levels, affecting 1 in 88 children. Meanwhile, doctors and researchers argue about the causes, whether it is genetic, the result of thimerosal or aluminum in vaccines, or antibiotics which wipe out the good bacteria and allow the pathogenic bacteria to take over in the intestines.

The research team led by Dae-Wook Kang at Arizona State University’s Biodesign Institute in Tempe, Arizona, recently published Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children. The nearly 100 trillion bacteria in the human intestines not only assist digestion and manufacture vitamins, but also help balance the immune system. Many autistic children suffer from digestive problems, and there is a very strong connection between digestive issues and the severity of autistic symptoms. In addition, the breakdown products of poor digestion can have a huge impact on the brain and nervous system, leading to ma
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Global Biomaterials Market 2012-2016: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report
2. Worldwide Medical Polymer Markets: 2013-2020: Worldwide Industry Latest Market Share, Strategy, Growth, Analysis, Size, Trends and Forecast Research Report 2020
3. The Global Next Generation Sequencing (NGS) Market is Poised to Reach $2.7 Billion by 2017 Says Latest Report
4. Global Activated Carbon Market 2012-2016: Latest Market Share, Growth, Analysis, Size, Trends & Forecast Research Report 2012-2016 Available at Marketresearchreports.biz
5. Medrio, a Leading EDC Provider for Clinical Research, Announces Its Latest Version, 8.1 with iPad Support, is Available Without Charge for Academic Researchers
6. Latest Cell Publication of OriGene and Peking University Collaborative Discovery of New iPSC Reprogramming Factors
7. Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post
8. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
9. Latest Advances in Treatment for Alzheimers, Traumatic Brain Injury and Stroke to Be Presented at Symposium
10. Online Courses Address Latest Healthcare Compliance Regulations
11. The Return of Extinct Animals – and Maybe Humans; Latest Topic by HuffPost Columnist and Sociologist Gini Graham Scott
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015 China Cord Blood Corporation (NYSE: CO) ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced that the Company has filed its Annual Report ... Commission. The filed Form 20-F includes audited financial statements ... Form 20-F can be accessed by visiting the U.S. ...
(Date:7/30/2015)... , July 30, 2015 AACC ... to the 2015 AACC Annual Meeting & Clinical ... from July 26–30. The meeting showcased revolutionary advancements ... the ability of healthcare providers to diagnose patients ... effective medical treatment. As of ...
(Date:7/30/2015)... Dallas, Texas (PRWEB) , ... July 30, 2015 , ... ... professional and in-depth study on the current state of the global Propanol market with ... are Sinopec, CNPC, BASF, Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal ...
(Date:7/30/2015)... KANSAS CITY, Kan. , July 30, 2015 ... PETX ), a pet therapeutics company focused on ... products for companion animals, today announced that its ... results from a dose confirmation study of AT-016, ... to Aratana for the treatment of osteoarthritis pain ...
Breaking Biology Technology:China Cord Blood Corporation Files Its Annual Report on Form 20-F 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5
... 17 , - New ... Short-Term Mortality Compared to Previous Treatments , ... positive final results,from a Phase II trial of its ... acute myeloid leukaemia (AML). In the,trial, elacytarabine showed statistically ...
... , SHANGHAI, June 17 ... ("China-Biotics", "the Company"), a leading Chinese firm,specializing in ... products, today announced it will join the Russell,3000(R) ... its comprehensive set of U.S. and global equity ...
... (Nasdaq: PRXL ) announced today it will be ... Boston. James Winschel, Senior Vice President & Chief Financial ... 10:15 a.m. EDT on Tuesday, June 23, 2009. ... be available through the "Investor Relations - Upcoming Events" ...
Cached Biology Technology:Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 7China-Biotics, Inc. to Join Russell 3000 Index 2China-Biotics, Inc. to Join Russell 3000 Index 3PAREXEL International to Present at the Wachovia Equity Conference 2
(Date:7/8/2015)... N.J. and NEW YORK , July 8, ... Guidepoint today announced BD & Guidepoint Mentor, ... with free access to Guidepoint,s expert network services. ... are developing cutting-edge technologies to improve healthcare delivery and ... research manager, each start-up entrepreneur will be able to ...
(Date:7/7/2015)... Calif. , July 7, 2015  Based ... market, Frost & Sullivan recognizes Credence ID, LLC ... Entrepreneurial Company of the Year Award. Credence ... to aid in its mission of offering enrollment ... populations globally. As Credence ID was formed by ...
(Date:7/2/2015)... July 2, 2015 Fingerprint Cards has ... FPC1145 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... will be used by smartphone manufacturers in Asia ... in the communicated revenue guidance of approximately 2,200 MSEK for ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... ability to promote agricultural and conservation successes in the ... scientists, understanding of how plants adapt to local climate. ... study in the Oct. 7, 2011 issue of ... adaptations to local climate. The National Science Foundation ...
... Agrarian Research (IVIA, Spain) have created a machine that ... segments according to their quality and another that helps ... use computer vision to automatically inspect the fruits. ... dark rooms with the help of ultraviolet light that ...
... York Stem Cell Foundation (NYSCF) announced today that a British ... first recipient of The New York Stem Cell Foundation ... annually for extraordinary achievement in translational stem cell research. ... Director of the London Project to Cure Blindness and Professor ...
Cached Biology News:Oranges and mandarins are inspected using artificial vision 2Oranges and mandarins are inspected using artificial vision 3Professor Peter J. Coffey's stem cell therapy for Age-Related Macular Degeneration expected to begin clinical trials in 2012 2Professor Peter J. Coffey's stem cell therapy for Age-Related Macular Degeneration expected to begin clinical trials in 2012 3
Human MFRP MAb (Clone 291218)...
Human RELT/TNFRSF19L MAb (Clone 238104)...
...
... assay kit measures NOS activity by monitoring ... This assay is simple, sensitive, and specific ... with both crude and purified enzyme preparations. ... for 50 total reactions. Radiolabeled arginine and ...
Biology Products: